FCN1 and cancer: Furthermore, FCN1 expression exhibited significant associations with molecular subtypes and clinical stages across various tumors (Supplementary Figure S1E; Supplementary Figure S2A), suggesting that dysregulated FCN1 expression in diverse cancers may contribute to tumorigenesis and progression.